...
首页> 外文期刊>Cytotechnology >Catalyser-21TM, a mineral water derived from leaf soil, inhibits tumor cell invasion and angiogenesis
【24h】

Catalyser-21TM, a mineral water derived from leaf soil, inhibits tumor cell invasion and angiogenesis

机译:Catalyser-21TM是一种来自叶片土壤的矿泉水,可抑制肿瘤细胞的侵袭和血管生成

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Catalyser-21TM is a mineral water derived from natural leaf soil containing various organic and inorganic substances. Previous reports suggested a possibility that Catalyser-21TM has antioxidative potential and could inhibit angiogenesis and cancer cell invasiveness. Angiogenesis is a prerequisite for cancer cells to spread to surrounding tissues. Vascular endothelial growth factor (VEGF) is a major angiogenic factor in the formation of blood capillaries by cancer cells to supply nutrients and oxygen for their sustained growth. Matrix metalloproteinase-2 (MMP-2) is another key enzyme for cancer cell metastasis. To assess the anti-angiogenic activity of Catalyser-21TM, we first examined cell viability using a human cervical cancer cell line, HeLa, and a fibrosarcoma cell line, HT1080. The results showed that Catalyser-21TM decreased the viability of both cell types in a dose-dependent manner. Flow cytometric analysis proved that Catalyser-21TM scavenges intracellular H2O2 in both cell types. RT-PCR demonstrated that both VEGF and MMP-2 gene transcription was suppressed after Catalyser-21TM treatment. Both Matrigel and tubule formation experiments showed an effect of Catalyser-21TM. These results suggest that Catalyser-21TM has potential as an anti-tumor agent.
机译:Catalyser-21TM是一种矿泉水,是从天然叶土中提取的,含有多种有机和无机物质。先前的报道提示Catalyser-21TM具有抗氧化潜力并可能抑制血管生成和癌细胞侵袭的可能性。血管生成是癌细胞扩散到周围组织的先决条件。血管内皮生长因子(VEGF)是癌细胞形成毛细血管以为其持续生长提供营养和氧气的主要血管生成因子。基质金属蛋白酶2(MMP-2)是癌细胞转移的另一种关键酶。为了评估Catalyser-21TM的抗血管生成活性,我们首先使用人宫颈癌细胞系HeLa和纤维肉瘤细胞系HT1080检查了细胞活力。结果表明Catalyser-21TM以剂量依赖性方式降低了两种细胞的活力。流式细胞仪分析证明Catalyser-21TM清除了两种细胞类型的细胞内H2O2。 RT-PCR显示Catalyser-21TM处理后,VEGF和MMP-2基因的转录均被抑制。基质胶和肾小管形成实验均显示了Catalyser-21TM的作用。这些结果表明Catalyser-21TM具有作为抗肿瘤剂的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号